Tradestie Institutional Equity Comparison Engine

TNON vs GRML โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

TNON Overall Edge

TNON Captures Institutional Edge (1โ€“1 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Tenon Medical, Inc. Common Stock (TNON) driven by superior Growth & Margin while GRML counters with relative strength in Momentum & Technical. Fundamentally, TNON trades at N/M Forward P/E with -228.0% operating margin (+126.8% YoY revenue) versus GRML at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, TNON sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against GRML sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
TNON N/M vs GRML N/M Fwd P/E
Growth & Margin Winner TNON
Op Margin -228.0% vs N/A ยท YoY +126.8% vs N/A
Momentum & Technical Winner GRML
1Y +12.3% vs +650.0% ยท 52W Pos 7% vs 19%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
TNON NASDAQ
Tenon Medical, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$1.32
-6.03% 1D
Market Cap $3.8M
1M Return -50.93%
1Y Return +12.29%
Forward P/E N/M
Unified AI Score
45.0 / 100 HOLD
Tech 33.0 Fund 50.0 Flow 50.0 Mom 60.0
GRML US Equity
GRML
Institutional Equity
$3.51
-2.77% 1D
Market Cap N/A
1M Return -41.5%
1Y Return +650.0%
Forward P/E N/M
Unified AI Score
56.8 / 100 HOLD
Tech 60.0 Fund 57.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: TNON +12.29% GRML +650.0% Spread: +585.44 pp (GRML Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
TNON TTM Op. Margin: -228.0% GRML TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on TNON vs GRML. Trailing 12-month operating profitability (TNON -228.0% vs GRML N/A) and valuation multiples (TNON N/M vs GRML N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: TNON (5) vs GRML (3)
Institutional Metric TNON GRML Criterion Row Winner
Market Capitalization Scale $3.8M N/A Larger Scale TNON
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +126.8% N/A Higher Growth TNON
Operating Margin (TTM) Profitability -228.0% N/A Higher Margin TNON
Net Profit Margin Profitability -257.9% N/A Higher Margin TNON
Return on Equity (ROE) Capital Efficiency -551.2% N/A Higher ROE TNON
52-Week Range Position Momentum 7% ($0โ€“$18) 19% ($0โ€“$18) Stronger Trend GRML
Beta / 30D Volatility Risk Regime -1.56ฮฒ ยท 106% Vol -5.32ฮฒ ยท 95% Vol Lower Realized Risk GRML
Unified Institutional Score Composite Signal 45.0 / 100 (HOLD) 56.8 / 100 (HOLD) Higher Composite GRML

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full TNON vs GRML Buy Guide
TNON UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live TNON Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
GRML UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live GRML Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither TNON nor GRML registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.